Mount Yale Investment Advisors LLC Trims Stake in MetLife, Inc. (NYSE:MET)

Mount Yale Investment Advisors LLC cut its stake in MetLife, Inc. (NYSE:METFree Report) by 27.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 10,493 shares of the financial services provider’s stock after selling 3,906 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in MetLife were worth $859,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. MeadowBrook Investment Advisors LLC raised its position in shares of MetLife by 244.4% in the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. grew its stake in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC grew its stake in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 277 shares during the period. Peterson Financial Group Inc. bought a new position in MetLife in the third quarter worth $30,000. Finally, Retirement Wealth Solutions LLC purchased a new position in MetLife during the fourth quarter valued at $32,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Price Performance

NYSE MET opened at $86.97 on Tuesday. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05. The stock has a 50-day moving average of $83.81 and a 200 day moving average of $80.11. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The company has a market capitalization of $60.22 billion, a price-to-earnings ratio of 17.53, a PEG ratio of 0.65 and a beta of 1.07.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.51%. MetLife’s payout ratio is 43.95%.

Analysts Set New Price Targets

Several research analysts recently issued reports on MET shares. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen raised their target price on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. JPMorgan Chase & Co. boosted their price target on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. BMO Capital Markets initiated coverage on MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price target on the stock. Finally, Barclays lifted their price objective on MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.46.

View Our Latest Analysis on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Further Reading

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.